Showing results (91-100 of 112) with videos related to
Sort By:
Pageof 12
Oncology Reports|December 29, 1998
Radioimmunotherapy of orthotopically transplanted pancreatic cancer with 131I-labeled chimeric monoclonal antibody Nd2A Yamamoto, T Sawada, Y Yamashita, et al.Hepatology (Baltimore, Md.)|November 26, 1999
Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinomaM Higashi, S Yonezawa, J J Ho, et al.Cancer Research|January 1, 1991
Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucinJ J Ho, N Bi, P S Yan, et al.International Journal of Cancer|May 28, 1993
Monoclonal antibody directed against colon cancer mucin has high specificity for malignancyB Siddiki, J J Ho, J Huang, et al.International Journal of Cancer|July 29, 1997
Expression of mucin-associated tumor antigens is altered by cell densityY Yamashita, J J Ho, S Cheng, et al.Japanese Journal of Cancer Research : Gann|September 1, 1996
Radioimmunotherapy for pancreatic carcinoma using (131)I-labeled monoclonal antibody Nd2 in xenografted nude miceA Inui, Y S Chung, T Sawada, et al.Japanese Journal of Cancer Research : Gann|August 31, 2000
Antibody-dependent cytotoxicity mediated by chimeric monoclonal antibody Nd2 and experimental immunotherapy for pancreatic cancerT Nishihara, T Sawada, A Yamamoto, et al.Biochemical and Biophysical Research Communications|September 15, 1993
Biphasic effect of cell surface sialic acids on pancreatic cancer cell adhesivenessT Sawada, J J Ho, T Sagabe, et al.Epidemiology and Infection|March 13, 2015
Incidence of percutaneous injury in Taiwan healthcare workersH C Wu, J J Ho, M H Lin, et al.Alimentary Pharmacology & Therapeutics|June 4, 2005
Human leucocyte antigen determinants of susceptibility to Barrett's oesophagus in Asians--a preliminary studyS Rajendra, R Ackroyd, S Murad, et al.Pageof 12